Robert Schrepfer

2018

In 2018, Robert Schrepfer earned a total compensation of $1.4M as Senior Vice President, New Business Development and Specialty Sales at ANI Pharmaceuticals, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$240,300
Option Awards$301,344
Salary$431,159
Stock Awards$456,480
Other$14,873
Total$1,444,156

Schrepfer received $456.5K in stock awards, accounting for 32% of the total pay in 2018.

Schrepfer also received $240.3K in non-equity incentive plan, $301.3K in option awards, $431.2K in salary and $14.9K in other compensation.

Rankings

In 2018, Robert Schrepfer's compensation ranked 7,345th out of 14,244 executives tracked by ExecPay. In other words, Schrepfer earned more than 48.4% of executives.

ClassificationRankingPercentile
All
7,345
out of 14,244
48th
Division
Manufacturing
2,848
out of 5,765
51st
Major group
Chemicals And Allied Products
1,071
out of 2,128
50th
Industry group
Drugs
905
out of 1,817
50th
Industry
Pharmaceutical Preparations
709
out of 1,391
49th

Pay ratio

Robert Schrepfer's Pay$1,444,156
Median Employee's Pay$52,389
Pay Ratio

28

to 1

In 2018, the annual total compensation of Robert Schrepfer was $1,444,156.

The annual total compensation of the median employee at ANI Pharmaceuticals was $52,389.

The ratio of Robert Schrepfer's pay to the pay of median employee was therefore 28 to one.

Source: SEC filing on April 4, 2019.

Schrepfer's colleagues

We found three more compensation records of executives who worked with Robert Schrepfer at ANI Pharmaceuticals in 2018.

2018

Arthur Przybyl

ANI Pharmaceuticals

Chief Executive Officer

2018

Stephen Carey

ANI Pharmaceuticals

Chief Financial Officer

2018

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

News

You may also like